Physician profile
Robert Locastro
NPI 1982606323
$3,720.35
in general payments reported to CMS, 2019-2025
18 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what 81% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $150 · 2021: $326 · 2022: $276 · 2023: $831 · 2024: $769 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,662.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $664.04 | 2019-2024 | |
| Stryker Corporation | $614.58 | 2019-2025 | Hoffmann, Augment Injectable, Actishield |
| Organogenesis INC. | $396.08 | 2021-2025 | Puraply, Affinity |
| Smith+Nephew, INC. | $331.92 | 2023-2025 | Collagenase Santyl, Grafix Pl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Paratek Pharmaceuticals, INC. | $241.60 | 2025 | Nuzyra |
| Acera Surgical, INC. | $180.59 | 2024 | Restrata Wound Matrix |
| Next Science LLC | $144.94 | 2023 | Xperience, Blastx, Surgx |
| Spr Therapeutics, INC | $141.38 | 2025 | Sprint Pns System |
| Advanced Oxygen Therapy INC. | $140.00 | 2024 | Topical Oxygen Chamber For Extremities |
| Lifenet Health | $139.60 | 2025 | Theragenesis Wound Matrix |
| Linvatec Corporation | $136.54 | 2021 | |
| Ani Pharmaceuticals, INC. | $125.00 | 2024 | Purified Cortrophin Gel |
| Abbott Laboratories | $125.00 | 2023 | Diamondback Peripheral |
| Amgen INC. | $110.77 | 2025 | Krystexxa |
| Extremity Medical | $106.43 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $84.09 | 2021 | |
| Integra Lifesciences Corporation | $23.49 | 2020 | |
| Averitas Pharma INC. | $14.30 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Locastro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.